 Enanta Pharmaceuticals, Inc. NASDAQ:ENTA Q3 2022 Earnings Conference Call August 8, 2022 4:30 PM ET Company Participants Jennifer Viera - Senior Director, IR Corporate Communications Jay Luly - President, CEO Director Paul Mellett - SVP, Finance Administration CFO Tara Kieffer - SVP, New Product Strategy Development Conference Call Participants Douglas Buchanan - JMP Securities Brian Skorney - Robert W. Baird Co. Hannah Adeoye - JPMorgan Chase Co. Roanna Ruiz - SVB Securities Operator Good afternoon, and welcome to Enanta Pharmaceuticals Fiscal Third Quarter 2022 Financial Results Conference Call. 